Cho J - Search Results

1

Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung Cancer.

Song HN, Jung KS, Yoo KH, Cho J, Lee JY, Lim SH, Kim HS, Sun JM, Lee SH, Ahn JS, Park K, Choi YL, Park W, Ahn MJ. Song HN, et al. Among authors: cho j. J Thorac Oncol. 2016 Apr;11(4):e45-7. doi: 10.1016/j.jtho.2015.12.093. Epub 2015 Dec 31. J Thorac Oncol. 2016. PMID: 26749488 Free article.

2

Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea.

Kim HK, Ham JS, Byeon S, Yoo KH, Jung KS, Song HN, Cho J, Lee JY, Lim SH, Kim HS, Kim JY, Lee JE, Kim SW, Nam SJ, Lee SK, Bae SY, Ahn JS, Im YH, Park YH. Kim HK, et al. Among authors: cho j. Cancer Res Treat. 2016 Oct;48(4):1382-1388. doi: 10.4143/crt.2015.423. Epub 2016 Mar 11. Cancer Res Treat. 2016. PMID: 26987392 Free PMC article.

3

MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.

Lee JY, Lee I, Chang WJ, Ahn SM, Lim SH, Kim HS, Yoo KH, Jung KS, Song HN, Cho JH, Kim SY, Kim KM, Lee S, Kim ST, Park SH, Lee J, Park JO, Park YS, Lim HY, Kang WK. Lee JY, et al. Among authors: cho jh. Oncotarget. 2016 Jul 12;7(28):43492-43503. doi: 10.18632/oncotarget.9523. Oncotarget. 2016. PMID: 27224918 Free PMC article.

4

Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry.

Cho J, Ahn S, Yoo KH, Kim JH, Choi SH, Jang KT, Lee J. Cho J, et al. Invest New Drugs. 2016 Dec;34(6):677-684. doi: 10.1007/s10637-016-0373-4. Epub 2016 Aug 4. Invest New Drugs. 2016. PMID: 27491654

5

Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma.

Kim HK, Lee S, Kim K, Heo MH, Lee H, Cho J, Kim NKD, Park W, Lee SJ, Kim JH, Jang KT, Choi SH, Lee J. Kim HK, et al. Among authors: cho j. Transl Oncol. 2016 Dec;9(6):557-564. doi: 10.1016/j.tranon.2016.09.004. Epub 2016 Nov 22. Transl Oncol. 2016. PMID: 27883956 Free PMC article.

6

Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.

Cho J, Kim SJ, Park S, Yoo KH, Ki CS, Ko Y, Kim WS. Cho J, et al. Ann Hematol. 2018 Aug;97(8):1427-1436. doi: 10.1007/s00277-018-3313-x. Epub 2018 Apr 8. Ann Hematol. 2018. PMID: 29627879

7

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.

Cho J, Kim HS, Ku BM, Choi YL, Cristescu R, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Cho J, et al. J Clin Oncol. 2019 Aug 20;37(24):2162-2170. doi: 10.1200/JCO.2017.77.3184. Epub 2018 Jun 15. J Clin Oncol. 2019. PMID: 29906252 Clinical Trial.

8

Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data.

Kim EK, Cho J, Kim JY, Chang SA, Park SJ, Choi JO, Lee SC, Ahn JS, Park SW, Im YH, Jeon ES, Park YH. Kim EK, et al. Among authors: cho j. Cancer Res Treat. 2019 Apr;51(2):727-736. doi: 10.4143/crt.2018.262. Epub 2018 Sep 4. Cancer Res Treat. 2019. PMID: 30177584 Free PMC article.

9

A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13.

Yoo KH, Lee SJ, Cho J, Lee KH, Park KU, Kim KH, Cho EK, Choi YH, Kim HR, Kim HG, Ahn HJ, Lee HY, Yun HJ, Kang JH, Jeong J, Choi MY, Jung SH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Yoo KH, et al. Among authors: cho j, cho ek. Cancer Res Treat. 2019 Apr;51(2):718-726. doi: 10.4143/crt.2018.324. Epub 2018 Sep 3. Cancer Res Treat. 2019. PMID: 30177585 Free PMC article. Clinical Trial.

10

The First-week Proliferative Response of Peripheral Blood PD-1⁺CD8⁺ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors.

Kim KH, Cho J, Ku BM, Koh J, Sun JM, Lee SH, Ahn JS, Cheon J, Min YJ, Park SH, Park K, Ahn MJ, Shin EC. Kim KH, et al. Among authors: cho j. Clin Cancer Res. 2019 Apr 1;25(7):2144-2154. doi: 10.1158/1078-0432.CCR-18-1449. Epub 2019 Jan 15. Clin Cancer Res. 2019. PMID: 30647082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,383 results

Search Page